Loading...
XNASCTSH
Market cap39bUSD
Dec 24, Last price  
79.49USD
1D
0.62%
1Q
5.24%
Jan 2017
41.87%
Name

Cognizant Technology Solutions Corp

Chart & Performance

D1W1MN
XNAS:CTSH chart
P/E
18.54
P/S
2.04
EPS
4.29
Div Yield, %
1.50%
Shrs. gr., 5y
-2.87%
Rev. gr., 5y
3.72%
Revenues
19.35b
-0.39%
586,673,000885,830,0001,424,267,0002,135,577,0002,816,304,0003,278,663,0004,592,389,0006,121,156,0007,346,472,0008,843,189,00010,262,681,00012,416,000,00013,487,000,00014,810,000,00016,125,000,00016,783,000,00016,652,000,00018,507,000,00019,428,000,00019,353,000,000
Net income
2.13b
-7.16%
100,243,000166,266,000232,795,000350,133,000430,845,000534,963,000733,540,000883,618,0001,051,263,0001,228,578,0001,439,267,0001,623,600,0001,553,000,0001,504,000,0002,101,000,0001,842,000,0001,392,000,0002,137,000,0002,290,000,0002,126,000,000
CFO
2.33b
-9.27%
127,333,000159,760,000252,876,000344,320,000429,705,000672,325,000764,654,000875,152,0001,172,583,0001,423,776,0001,473,010,0002,153,300,0001,621,000,0002,407,000,0002,592,000,0002,499,000,0003,299,000,0002,495,000,0002,568,000,0002,330,000,000
Dividend
Aug 20, 20240.3 USD/sh
Earnings
Feb 04, 2025

Profile

Cognizant Technology Solutions Corporation, a professional services company, provides consulting and technology, and outsourcing services in North America, Europe, and internationally. It operates through four segments: Financial Services; Healthcare; Products and Resources; and Communications, Media and Technology. The company offers customer experience enhancement, robotic process automation, analytics, and AI services in areas, such as digital lending, fraud detection, and next generation payments; the shift towards consumerism, outcome-based contracting, digital health, delivering integrated seamless, omni-channel, and patient-centered experience; and services that drive operational improvements in areas, such as clinical development, pharmacovigilance, and manufacturing, as well as claims processing, enrollment, membership, and billing to healthcare providers and payers, and life sciences companies, including pharmaceutical, biotech, and medical device companies. It also provides solution to manufacturers, retailers and travel and hospitality companies, as well as companies providing logistics, energy and utility services; and digital content, the creation of personalized user experience, and acceleration of digital engineering services to information, media and entertainment, and communications and technology companies. The company was founded in 1994 and is headquartered in Teaneck, New Jersey.
IPO date
Jun 24, 1998
Employees
345,600
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
19,353,000
-0.39%
19,428,000
4.98%
18,507,000
11.14%
Cost of revenue
12,664,000
12,448,000
11,604,000
Unusual Expense (Income)
NOPBT
6,689,000
6,980,000
6,903,000
NOPBT Margin
34.56%
35.93%
37.30%
Operating Taxes
668,000
730,000
693,000
Tax Rate
9.99%
10.46%
10.04%
NOPAT
6,021,000
6,250,000
6,210,000
Net income
2,126,000
-7.16%
2,290,000
7.16%
2,137,000
53.52%
Dividends
(591,000)
(564,000)
(509,000)
Dividend yield
1.55%
1.90%
1.09%
Proceeds from repurchase of equity
(993,000)
(1,336,000)
(641,000)
BB yield
2.60%
4.50%
1.37%
Debt
Debt current
339,000
182,000
233,000
Long-term debt
1,805,000
2,240,000
2,387,000
Deferred revenue
42,000
19,000
40,000
Other long-term liabilities
526,000
645,000
665,000
Net debt
(571,000)
(506,000)
(562,000)
Cash flow
Cash from operating activities
2,330,000
2,568,000
2,495,000
CAPEX
(317,000)
(332,000)
(279,000)
Cash from investing activities
(331,000)
(106,000)
(2,164,000)
Cash from financing activities
(1,609,000)
(1,939,000)
(1,203,000)
FCF
6,035,000
6,104,000
5,879,000
Balance
Cash
2,635,000
2,501,000
2,719,000
Long term investments
80,000
427,000
463,000
Excess cash
1,747,350
1,956,600
2,256,650
Stockholders' equity
13,212,000
12,294,000
11,964,000
Invested Capital
13,515,650
12,333,400
12,007,350
ROIC
46.59%
51.35%
53.84%
ROCE
43.19%
48.24%
47.67%
EV
Common stock shares outstanding
505,000
519,000
528,000
Price
75.53
32.07%
57.19
-35.54%
88.72
8.26%
Market cap
38,142,650
28.51%
29,681,610
-36.64%
46,844,160
5.66%
EV
37,571,650
29,175,610
46,282,160
EBITDA
7,208,000
7,549,000
7,477,000
EV/EBITDA
5.21
3.86
6.19
Interest
41,000
19,000
9,000
Interest/NOPBT
0.61%
0.27%
0.13%